Advertisement
Advertisement

TMDX

TMDX logo

TransMedics Group, Inc. Common Stock

89.98
USD
Sponsored
+3.00
+3.45%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

87.84

-2.14
-2.38%

TMDX Earnings Reports

Positive Surprise Ratio

TMDX beat 18 of 30 last estimates.

60%

Next Report

Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$180.55M
/
$0.30
Implied change from Q2 26 (Revenue/ EPS)
-4.95%
/
-31.82%
Implied change from Q3 25 (Revenue/ EPS)
+25.54%
/
-54.55%

TransMedics Group, Inc. Common Stock earnings per share and revenue

On Aug 04, 2026, TMDX reported earnings of 0.44 USD per share (EPS) for Q2 26, missing the estimate of 0.48 USD, resulting in a -8.86% surprise. Revenue reached 189.95 million, compared to an expected 187.31 million, with a 1.41% difference. The market reacted with a -5.28% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 12 analysts forecast an EPS of 0.30 USD, with revenue projected to reach 180.55 million USD, implying an decrease of -31.82% EPS, and decrease of -4.95% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Electromed, Inc.
Report Date
Aug 25, 2026 For Q4 26
Estimate
$0.31
Actual
$0.39
Surprise
+23.34%
FAQ
For Q2 2026, TransMedics Group, Inc. Common Stock reported EPS of $0.44, missing estimates by -8.86%, and revenue of $189.95M, 1.41% above expectations.
The stock price moved down -5.28%, changed from $80.75 before the earnings release to $76.49 the day after.
The next earning report is scheduled for Oct 27, 2026.
Based on 12 analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.30 and revenue of $180.55M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement